| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 | May 15, 2023 | Editas Medicine, Inc. | CFO | Sell | 50.0 | -949 | -0.88% | ✗ | $9.4K |
| Mar 2, 2023 | Mar 6, 2023 | Editas Medicine, Inc. | CFO | Sell | 90.0 | +31,316 | 41.07% | ✗ | $1.6K |
| Feb 13, 2023 | Feb 15, 2023 | Editas Medicine, Inc. | CFO | Sell | 46.3 | -4,287 | -5.32% | ✗ | $41.4K |
| Jan 10, 2023 | Jan 12, 2023 | Editas Medicine, Inc. | CFO | Sell | 46.3 | -1,752 | -2.13% | ✗ | $14.3K |
| Dec 5, 2022 | Dec 6, 2022 | Editas Medicine, Inc. | CFO | Sell | 52.5 | -193 | -0.23% | ✗ | $2K |
| Sep 6, 2022 | Sep 8, 2022 | Editas Medicine, Inc. | CFO | Sell | 52.5 | -192 | -0.23% | ✗ | $2.9K |
| Jun 3, 2022 | Jun 6, 2022 | Editas Medicine, Inc. | CFO | Sell | 46.3 | -1,527 | -1.81% | ✗ | $17.6K |
| Mar 3, 2022 | Mar 7, 2022 | Editas Medicine, Inc. | CFO | Sell | 48.8 | -767 | -0.90% | ✗ | $13.3K |
| Jan 11, 2022 | Jan 13, 2022 | Editas Medicine, Inc. | CFO | Sell | 46.3 | -1,744 | -5.25% | ✗ | $44.8K |
| Aug 9, 2021 | Aug 10, 2021 | Editas Medicine, Inc. | CFO | Sell | 28.8 | -2,500 | -8.00% | ✓ | $150K |
| Jun 28, 2021 | Jun 30, 2021 | Editas Medicine, Inc. | CFO | Sell | 28.8 | -2,500 | -8.00% | ✓ | $125K |
| Jan 12, 2021 | Jan 13, 2021 | Editas Medicine, Inc. | CFO | Sell | 42.5 | -1,568 | -7.84% | ✗ | $122.7K |